Achilles Therapeutics plc Quarterly Common Stock, Shares, Issued from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Achilles Therapeutics plc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 41.1M shares, a 0.35% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 41.1M +142K +0.35% Jun 30, 2024 6-K 2024-08-14
Q4 2023 41.1M +150K +0.37% Dec 31, 2023 6-K 2024-08-14
Q2 2023 40.9M Jun 30, 2023 6-K 2023-08-04
Q4 2022 40.9M +329K +0.81% Dec 31, 2022 20-F 2024-04-04
Q4 2021 40.6M +36.2M +825% Dec 31, 2021 20-F 2023-03-07
Q4 2020 4.39M Dec 31, 2020 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.